Axxcess Wealth Management
NAUT icon

Axxcess Wealth Management’s Nautilus Biotechnolgy NAUT Stock Holding History

Axxcess Wealth Management’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,000
Closed -$29.9K – 909
2023
Q4 		$29.9K Buy
+10,000
New +$28.6K ﹤0.01% 823

Other funds holding NAUT

AH Capital Management
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Amazon.com Inc
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Axxcess Wealth Management's NAUT Position: Q1 2024 in Review

Axxcess Wealth Management sold out of Nautilus Biotechnolgy (NAUT) in Q1 2024, closing a stake of 10,000 shares — an estimated $29.9K sold.

Axxcess Wealth Management first reported a position in NAUT in Q4 2023 and held it in 1 quarter. The position peaked at $29.9K in Q4 2023. 73 funds tracked by Wall St. Rank hold NAUT as of Q1 2024.

  • Axxcess Wealth Management reported no remaining Nautilus Biotechnolgy position as of Q1 2024 after selling out during the quarter.
  • Axxcess Wealth Management sold 10,000 Nautilus Biotechnolgy shares in Q1 2024, an estimated $29.9K.
  • Axxcess Wealth Management first reported a position in Nautilus Biotechnolgy in Q4 2023 and held it in 1 quarter.
  • Axxcess Wealth Management's Nautilus Biotechnolgy position peaked at $29.9K in Q4 2023.
  • 73 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2024.

Based on Axxcess Wealth Management's 13F filing for Q1 2024, filed 14 May 2024.